The global Cephalosporin Market garnered $11.86 billion in 2017, and is expected to reach $14.02 billion by 2025, registering a CAGR of 2.0% from 2018 to 2025. The report provides an extensive analysis of top impacting factors, market size & estimations, drivers & opportunities, key segments, and competitive intelligence.
Growth Drivers and Industry Trends
Rise in incidence of infectious diseases, surge in R&D activities for discovery of combination drugs, and increase in funding for antibiotics development drive the growth in the global cephalosporin market. However, side effects related to cephalosporin and antibiotic resistance restrain the market growth. On the other hand, new opportunities from emerging nations create opportunities for the future.
Download Report Sample at: https://www.alliedmarketresearch.com/request-sample/3510
Based on generation, the third-generation cephalosporin segment held the major position in 2017, contributing nearly two-fifths of the total share. This segment is expected to maintain its lead position throughout the forecast period. However, the fourth-generation cephalosporin segment would grow at the highest CAGR of 2.8% from 2018 to 2025. The research also analyzes first-generation, second-generation, and fifth-generation cephalosporin.
Segmentation Analysis of the Industry
Based on type, the branded segment contributed the highest market share, accounting for nearly three-fifths of the total share in 2017, and is expected to continue to dominate throughout the forecast period. This segment would register the highest growth rate, with a CAGR of 2.3% from 2018 to 2025. It is a lucrative segment and present numerous growth opportunities. The report also explores generic type of cephalosporin.
Asia-Pacific contributed the largest market share based on revenue in 2017, accounting for nearly three-fifths of the total share. This region would continue to dominate in terms of revenue during the forecast period. However, LAMEA is expected grow at the fastest CAGR of 4.2% during the forecast period, 2018–2025. The research also analyzes other regions including North America and Europe.
Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3510
Industry Key Players
Leading market players active in the global cephalosporin market include
- Allergan Plc.,
- Hoffmann-La Roche Ltd.,
- Bristol-Myers Squibb Company,
- Lupin Limited (Lupin Pharmaceuticals, Inc.),
- GlaxoSmithKline Plc,
- Novartis International AG,
- Merck & Co. Inc.,
- Sanofi, Pfizer Inc.,
- Teva Pharmaceutical Industries Ltd.
They have adopted various strategies including partnerships, collaborations, mergers & acquisitions, and others to gain a strong position and sustain in the industry.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Similar Reports:
STD Testing Market – Global Opportunity Analysis and Industry Forecast, 2020–2027
Healthcare App Market – Global Opportunity Analysis and Industry Forecast, 2019-2027
Teleradiology Market – Global Opportunity Analysis and Industry Forecast, 2019-2027
Neurology Devices market – Global Opportunity Analysis and Industry Forecast, 2019–2027
Disposable Syringes Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
Surrogacy Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
Immunosuppressants Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research